About 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide
3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide (PubChem CID 67157488) has the molecular formula C29H32N4O7S
and a molecular weight of 580.66 g/mol. Its IUPAC name is 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide.
Analyze 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide?
The IUPAC name of 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide (CID 67157488) is 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide.
What is the SMILES notation for 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide?
The canonical SMILES for 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide is C[C@@H](CO)Oc1cc(Oc2ccc3c(c2)OCCN(Cc2ccccc2)S3(O)O)cc(C(=O)Nc2ccn(C)n2)c1.
What is the InChIKey of 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide?
The InChIKey is SZPLFYGHTDLADV-FQEVSTJZSA-N. The full InChI is InChI=1S/C29H32N4O7S/c1-20(19-34)39-24-14-22(29(35)30-28-10-11-32(2)31-28)15-25(16-24)40-23-8-9-27-26(17-23)38-13-12-33(41(27,36)37)18-21-6-4-3-5-7-21/h3-11,14-17,20,34,36-37H,12-13,18-19H2,1-2H3,(H,30,31,35)/t20-/m0/s1.
What are the key properties of 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide?
3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide has a molecular weight of 580.66 g/mol, XLogP of 5.14, 9 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(2-benzyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-7-yl)oxy]-5-[(2S)-1-hydroxypropan-2-yl]oxy-N-(1-methylpyrazol-3-yl)benzamide is sourced from PubChem (CID 67157488), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).